Viewbix Inc. (VBIX)

NCM – Real vaqt narxi. Valyuta: USD

3.64

0.00 (0.00%)

Yopilishda: May 15, 2026, 4:00 PM EDT

27.05.2026

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Toronto, Ontario – May 27, 2026 - TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), is providing the following update with respect to its previously announced proposed acquisition (the " Transaction ") of approximately 54.01% of the issued and outstanding ordinary shares (the “ Purchased Shares ”) of CliniQuantum Ltd. (" CliniQuantum "), as initially announced by news release dated March 10, 2026. The Company is providing this news release to supplement the disclosure contained in its March 10, 2026 news release, including in respect of (i) the license agreement between CliniQuantum and Quantum X Labs Ltd., (ii) the basis for the consideration payable under the Transaction and the fairness opinion received by the Company's board of directors, (iii) certain amendments to the share purchase agreement dated March 9, 2026 (the “ SPA ”) between the Company, CliniQuantum and the holders of the Purchased Shares (the “ Selling Shareholders ”), including the establishment of a floor price for future share issuances, an extension of the outside date, and the execution of lock-up arrangements by the Selling Shareholders as a condition of closing.

21.04.2026

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”). The rebranding represents the Company's evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.

30.03.2026

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Tel Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that Nuclear Quantum, a portfolio company of its wholly-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has achieved a strategic milestone.

20.03.2026

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

Tel Aviv, Israel, March 20, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that its fully-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for a novel nuclear magnetic resonance (NMR) gyroscope hardware architecture designed to deliver ultra-high precision rotational sensing at significantly lower cost than existing solutions.

19.03.2026

After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch

Moonage Media reviews the emerging quantum sector in the capital markets following Viewbix's acquisition of Quantum X Labs HONG KONG, March 19, 2026 /PRNewswire/ -- In the rapidly evolving quantum technology landscape, where giants like IBM and Google dominate headlines with massive R&D investments and breakthroughs in scalable quantum computing, smaller players are quietly carving out specialized niches. On March 4, 2026, Viewbix Inc. (NASDAQ: VBIX) completed its strategic acquisition of Quantum X Labs Ltd.

05.03.2026

Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Tel Aviv, Israel, March 05, 2026 (GLOBE NEWSWIRE) -- The acquisition encompasses Quantum 's proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction

04.03.2026

Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

The acquisition encompasses Quantum 's proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction Tel Aviv, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that it has completed the acquisition of 100% of Quantum X Labs Ltd. (“Quantum”), a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation, and atomic clocks, pursuant to the definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”).

Videolar

No Data

There is no data to display

Press-relizlar

27.05.2026

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

21.04.2026

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

30.03.2026

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

20.03.2026

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

Viewbix Inc. (VBIX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Viewbix Inc. (VBIX)

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch

Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

Videolar

No Data

Press-relizlar

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch

Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

Videolar

No Data

Press-relizlar

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

Search stocks

Viewbix Inc. (VBIX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Viewbix Inc. (VBIX)

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch

Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

Videolar

No Data

Press-relizlar

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency

After the Viewbix-Quantum X Labs Closing: 5 Nasdaq Quantum Stocks to Watch

Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

Videolar

No Data

Press-relizlar

Neurothera Labs Inc. Provides Update On Proposed Acquisition Of Majority Stake In Cliniquantum Ltd.

Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Files US Patent Application for a Nuclear Magnetic Resonance (NMR) Gyroscope Hardware Technology, to Reduce and Replace GPS dependency